TY - JOUR T1 - Hypothyroid ataxia complicating monoclonal antibody therapy JF - Practical Neurology JO - Pract Neurol DO - 10.1136/practneurol-2017-001713 SP - practneurol-2017-001713 AU - Abdul Badran AU - Carla Moran AU - Alasdair J Coles Y1 - 2017/08/04 UR - http://pn.bmj.com/content/early/2017/08/04/practneurol-2017-001713.abstract N2 - We present a case of cerebellar dysfunction due to severe hypothyroidism induced by pembrolizumab, a member of the ‘immune checkpoint inhibitor’ class of cancer immunotherapies. Thyroxine replacement completely resolved his symptoms and signs. We also discuss the neurological immune-related complications of checkpoint inhibitors. ER -